RAP 0.00% 20.5¢ raptor resources limited

Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-63

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,100 Posts.
    lightbulb Created with Sketch. 175
    I have to admit that I had lost faith in Management's ability to take the App through to commercialisation mainly due to my perception that the medical fraternity would not allow the device to impinge on their God given right to be the sole arbiter of respiratory diagnosis. This announcement appears to knock that perception on the head as doctors now see ResAppDx-Eu as being "invaluable" in helping them make differential diagnoses of respiratory disease. If there has been one good thing to come out of COVID-19, then this is it. I am now once again a "true believer".
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.